Search results
Found 12418 matches for
Dr Fadi Issa has received a gentleMACST Octo Dissociator from global biotechnology company Miltenyi Biotec following a competition draw.
Carcinoma in situ presented at EuropaDonna
Work on breast carcinoma in situ was discussed with members of the patient advocate organisation, EuropaDonna in October 2024.